Efficacy of Cabergoline in Japanese Patients with Sporadic Acromegaly and AIP Gene Mutations

Trial Profile

Efficacy of Cabergoline in Japanese Patients with Sporadic Acromegaly and AIP Gene Mutations

Completed
Phase of Trial: Clinical Phase Unknown

Latest Information Update: 24 Aug 2015

At a glance

  • Drugs Cabergoline (Primary)
  • Indications Acromegaly; Pituitary adenoma
  • Focus Therapeutic Use
  • Most Recent Events

    • 24 Aug 2015 New trial record
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top